Sinopharm, China NT Form JV For Vaccines
This article was originally published in PharmAsia News
China's Sinopharm and China NT Pharma plan a $32.3 million joint venture to distribute the former company's vaccines and other products.
You may also be interested in...
France has announced a number of emergency measures to protect drug supplies threatened by the spread of the coronavirus.
Major generics companies have donated hydroxychloroquine sulfate doses for research and treatment of coronavirus. Companies are also donating hand sanitizer and personal protective equipment and are preparing to ramp up manufacturing and production.
Inovio forges ahead into Phase I trials with DNA-based vaccine candidate, but can it prove skeptics wrong?